Valeur Intrinsèque du S&P et Nasdaq Contactez-nous

Axonics, Inc. AXNX NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
52/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$71.00
+0%

Il y a eu 50 transactions d'initiés récentes enregistrées pour Axonics, Inc. (AXNX), dont 6 achats et 42 ventes. Le total des achats d'initiés s'élève à RSU Award et le total des ventes d'initiés à $9.99M.

Les initiés notables ayant une activité récente comprennent Keese Kari Leigh, Carrel Michael H, Cohen Raymond W. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — AXNX

Date Nom Rôle Type de Transaction Actions Prix Moyen Valeur Actions détenues
2025-01-31 Keese Kari Leigh Chief Financial Officer Cession 2,083 - - -
2024-11-15 Carrel Michael H Director Restitution d'Actions 10,000 $20.85 $208.5K -
2024-11-15 Cohen Raymond W Chief Executive Officer Restitution d'Actions 106,776 $1.63 $174.04K -
2024-11-15 Ford Alfred J Jr Chief Commercial Officer Restitution d'Actions 4,655 $25.82 $120.19K -
2024-11-15 Kiernan Jane E Director Restitution d'Actions 19,861 $71.00 $1.41M -
2024-11-15 Mcnamara Robert Director Restitution d'Actions 5,000 $14.80 $74K -
2024-11-15 Demski David M Director Restitution d'Actions 10,000 $51.70 $517K -
2024-11-15 Snyderman Nancy Lynn Md Director Restitution d'Actions 10,000 $21.04 $210.4K -
2024-11-15 Noblett Karen Chief Medical Officer Restitution d'Actions 11,998 $1.63 $19.56K -
2024-11-15 Sama Rinda Chief Operating Officer Restitution d'Actions 6,294 $1.63 $10.26K -
2024-11-15 Woock John EVP, Chief Mktg/strtgy Officer Restitution d'Actions 3,581 $25.82 $92.46K -
2024-11-15 Lopez Esteban Director Restitution d'Actions 10,000 $59.70 $597K -
2024-11-15 Keese Kari Leigh Chief Financial Officer Restitution d'Actions 3,125 - - -
2024-11-07 Snyderman Nancy Lynn Md Director Don (Donné) 5,000 - - 14,944
2024-10-02 Keese Kari Leigh Chief Financial Officer Vente Informative 2,597 $69.41 $180.25K 40,362
2024-07-24 Cohen Raymond W Chief Executive Officer Exercice d'Options (Vente) 78,125 $25.82 $2.02M -
2024-01-31 Cohen Raymond W Chief Executive Officer Exercice d'Options (Vente) 41,500 - - -
2024-01-31 Ford Alfred J Jr Chief Commercial Officer Exercice d'Options (Vente) 15,000 - - -
2024-01-31 Noblett Karen Chief Medical Officer Exercice d'Options (Vente) 15,000 - - -
2024-01-31 Sama Rinda Chief Operating Officer Exercice d'Options (Vente) 17,500 - - -
2024-01-31 Woock John EVP, Chief Mktg/strtgy Officer Exercice d'Options (Vente) 17,500 - - -
2024-01-31 Keese Kari Leigh Chief Financial Officer Exercice d'Options (Vente) 4,167 - - -
2024-01-08 Noblett Karen Chief Medical Officer Vente Informative 15,999 $69.00 $1.1M 18,216
2023-12-28 Noblett Karen Chief Medical Officer Vente Informative 7,051 $63.28 $446.18K 34,215
2023-12-26 Noblett Karen Chief Medical Officer Vente Informative 949 $63.00 $59.79K 41,266
2023-10-02 Keese Kari Leigh Chief Financial Officer Cession - - - 40,645
2023-09-29 Dearen Danny L. President & CFO Exercice d'Options (Vente) 11,250 - - -
2023-08-15 Ford Alfred J Jr Chief Commercial Officer Vente Informative 14,769 $62.34 $920.67K 34,565
2023-08-08 Carrel Michael H Director Don (Donné) 500 - - 17,861
2023-07-28 Ford Alfred J Jr Chief Commercial Officer Vente Informative 1,500 $62.01 $93.02K 49,334
2023-06-26 Carrel Michael H Director Attribution de RSU 3,000 - - 18,361
2023-06-26 Kiernan Jane E Director Attribution de RSU 3,000 - - 19,861
2023-06-26 Mcnamara Robert Director Attribution de RSU 3,000 - - 14,861
2023-06-26 Demski David M Director Attribution de RSU 3,000 - - 9,542
2023-06-26 Snyderman Nancy Lynn Md Director Attribution de RSU 3,000 - - 19,944
2023-06-26 Lopez Esteban Director Attribution de RSU 3,000 - - 6,600
2023-05-26 Dearen Danny L. President & CFO Vente Informative 300 $50.14 $15.04K 9,202
2023-04-21 Dearen Danny L. President & CFO Exercice d'Options (Vente) 13,208 $14.19 $187.42K -
2023-04-20 Dearen Danny L. President & CFO Exercice d'Options (Vente) 2,001 $14.19 $28.39K 13,208
2023-03-31 Dearen Danny L. Officer Exercice d'Options (Vente) 2,899 $1.63 $4.73K -
2023-02-21 Sama Rinda Officer Vente Informative 3,392 $56.53 $191.75K 608
2023-02-01 Cohen Raymond W Officer Vente Informative 6,932 $61.02 $422.96K 160,596
2023-02-01 Ford Alfred J Jr Officer Vente Informative 3,164 $61.02 $193.05K 50,834
2023-02-01 Noblett Karen Officer Vente Informative 795 $61.02 $48.51K 42,215
2023-02-01 Sama Rinda Officer Vente Informative 4,334 $61.02 $264.44K 75,783
2023-02-01 Woock John Officer Vente Informative 3,398 $61.02 $207.33K 65,302
2023-02-01 Dearen Danny L. Officer Vente Informative 2,772 $61.02 $169.14K 23,993
2023-01-31 Cohen Raymond W Officer Exercice d'Options (Vente) 40,000 - - -
2023-01-31 Ford Alfred J Jr Officer Exercice d'Options (Vente) 11,250 - - -
2023-01-31 Noblett Karen Officer Exercice d'Options (Vente) 6,000 - - -
Informatif — transaction sur marché ouvert (la plus significative) Non informatif (achat) — récompense, exercice d'option, conversion Non informatif (vente) — retenue fiscale, vente à l'acquisition Neutre — don, fiducie, expiration
Contactez-nous
🎓
SharesGrow Académie
Apprenez à calculer la Valeur Intrinsèque et trouver des actions sous-évaluées.
Sessions hebdomadaires en direct
Envoyez-nous un message